{
  "id": 14182338,
  "title": "Paragon spins out ninth biotech, sending cardiopulmonary drugs to Alaunos",
  "url": "https://urgent.news/2026/10/13/paragon-spins-out-ninth-biotech-sending-cardiopulmonary-drugs-to",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-13T11:00:48.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/paragon-spins-out-ninth-biotech-sending-cardiopulmonary-drugs-to-alaunos/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Paragon Labs has created a ninth company, using a reverse merger model that it’s honed over the past four years to send Velaris Therapeutics straight onto the public markets. Velaris completed a transaction on Tuesday ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}